Abo Bibliothek: Guest
International Journal of Medicinal Mushrooms

Erscheint 12 Ausgaben pro Jahr

ISSN Druckformat: 1521-9437

ISSN Online: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Taking Ingredients as an Entry Point to Explore the Relationship between the Shaggy Ink Cap Medicinal Mushroom, Coprinus comatus (Agaricomycetes), and Diabetes Mellitus (Review)

Volumen 21, Ausgabe 5, 2019, pp. 493-502
DOI: 10.1615/IntJMedMushrooms.2019030638
Get accessGet access

ABSTRAKT

Diabetes mellitus (DM) is a common endocrine and metabolic disease caused by protein and fat metabolism disorders as the main clinical manifestation due to the relative or absolute deficiency of insulin secretion in the body. Despite significant prevention and treatment efforts, the number of people with DM is still increasing. A safe and effective resource to prevent and treat DM is urgently needed. In recent years, many reports have indicated that medicinal mushrooms have a hypoglycemic effect. Among them, Coprinus comatus has great potential for development as a hypoglycemic drug or food; it is an emerging medicinal and edible fungus with a variety of nutrients (polysaccharides, unsaturated fatty acids, dietary fibers, vitamins, trace elements, amino acids, etc.). These ingredients have been closely linked to the hypoglycemic effects of C. comatus, possibly by increasing insulin release, protecting islet cells from invasion, enhancing antioxidant activity, regulating metabolic pathways, and reducing inflammation. This review preliminarily summarizes the hypoglycemic effect of C. comatus by introducing the ingredients it contains, which can provide theoretical support for the development of C. comatus as a potential hypoglycemic resource.

REFERENZIERT VON
  1. Sun Min, Wang Yongxia, Li Weidong, Cai Xiaoqing, Qi Dongmei, Zhang Yongqing, Han Chunchao, Comparison of the structures and prebiotic-like effects in vitro of polysaccharides from Coprinus comatus fruit body and mycelium, International Journal of Biological Macromolecules, 165, 2020. Crossref

  2. Arunachalam Karuppusamy, Sreeja Puthanpura Sasidharan, Yang Xuefei, The Antioxidant Properties of Mushroom Polysaccharides can Potentially Mitigate Oxidative Stress, Beta-Cell Dysfunction and Insulin Resistance, Frontiers in Pharmacology, 13, 2022. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain